Drug intelligence / Profile preview

microRNA-150 mimic

Development stage
Preclinical
Lead developer
Roswell Park Comprehensive Cancer Center
Modality
MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratracheal, Intranasal, Intravenous, Intraperitoneal, Subcutaneous
01

Overview

microRNA-150 mimic is a synthetic double-stranded RNA oligonucleotide designed to emulate the functional activity of endogenous microRNA-150 (miR-150). In the context of oncology, particularly breast cancer, miR-150 acts as a regulator of the tumor microenvironment by orchestrating immune activation and lymphocyte trafficking. The mimic is used to restore or enhance miR-150 levels, which has been shown to enrich multiple immune-related signaling pathways, including interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), and various interleukins (IL-2, IL-6). By modulating these pathways, the miR-150 mimic promotes the infiltration of CD8+ T cells, CD4+ memory T cells, and dendritic cells into the tumor, potentially improving cytolytic activity and overall survival in patients with breast cancer, especially those with ER-positive/HER2-negative subtypes.

Other names
miR-150 mimicmiR150 mimicmiR 150 mimichsa-miR-150 mimichsa-miR150 mimichsa-miR 150 mimicmicroRNA-150-5p mimicmicroRNA150-5p mimicmicroRNA 150-5p mimic

Beyond the preview

Go deeper on microRNA-150 mimic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA-150 mimic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call